In our study, using a different Bcl-xL AS oligonucleotide sequence in a different colon cancer cell line, the chemosensitisation approach was successfully extended to a more than 70% reduction of cell viability in combination with the cytotoxic chemotherapeutic agent cisplatin. Here, BCL2L1 is linked to malignant colon neoplasm.